Kristin Anderson, Ph.D. (Greenberg Lab, Fred Hutchinson)
Talk Title: Engineering Adoptive T cell Therapy for Efficacy in Ovarian Cancer

Cynthia Bamdad, Ph.D. (Minerva Biotechnologies)
Talk Title: CAR-T Cells Targeting Cleaved MUC1

Vita Golubovskaya, Ph.D. (Promab Biotechnologies)
Talk Title: Engineered Cytotoxic CAR-T cells with Decreased Cytokine Secretion

Sadik Kassim, Ph.D. (Mustang Bio)
Talk Title: The (Mis)measure of CAR-T Cells:  What Attributes Should We Measure for Solid and Liquid Tumor Directed CAR-T Cell Therapies?

Adam Snook, Ph.D. (Thomas Jefferson University)
Talk Title: GUCY2C-targeted CAR-T Cell Therapy for Gastrointestinal Cancers

Cheng Qian, M.D., Ph.D.(Third Military Medical University)
Talk Title: Treatment of Cancers with Adoptive Immunotherapy of Genetic Engineered T cells

Yama Abassi, Ph.D. (ACEA Biosciences, Inc.)
Talk Title: Advances in Immunotherapy using xCELLigence Technology

Mark Johnson, Ph.D.(Precision Biosciences)
Talk Title: Optimization of Nucleases for Gene-editing in Chimeric Antigen Receptor (CAR) T cell Manufacturing

Fabio Cerignoli, Ph.D. (ACEA Biosciences, Inc.)
Talk Title: The New “RTCA Pro” Software: Bringing Cell-Mediated Cytotoxicity Measurement to the Next Level

Brandon Lamarche, Ph.D. (ACEA Biosciences, Inc.)
Talk Title: Maximizing the Throughput and Reproducibility of Kinetic Scratch Assays by Combining xCELLigence With AccuWound^® 96